← All science articles

· 2 min read

PDRN Vaginal Suppositories Tested in Women With Cervical Ectropion

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

A small 1990 study examined whether polydeoxyribonucleotide (PDRN), a compound made of short DNA chains, could help women with cervical ectropion, a condition where tissue normally found inside the cervical canal appears on its outer surface and can cause irritation or discharge. De Luca Brunori and colleagues, writing in Annali di ostetricia, ginecologia, medicina perinatale in 1990, gave 30 women of reproductive age PDRN vaginal suppositories for 24 days, with no other local or general treatment allowed.

The researchers recorded patient-reported symptoms, how well the treatment was tolerated, cell samples from the vagina, a visual exam of the cervix (colposcopy), tissue samples taken before and after treatment, and markers of local immune activity. After treatment, the abstract reports lower symptom scores, "excellent or good" tolerability and acceptability, less inflammation, more iodine-staining of the tissue (a marker used to assess cervical tissue condition), and a shift back toward a more typical balance between two types of immune cells, T- and B-lymphocytes.

This is a human study, but the abstract gives no comparison group, no blinding, and no numerical results beyond these general descriptions. It does not state where the PDRN came from, its purity, or its fragment size, and it cannot show how PDRN would compare with no treatment or another therapy.

Our reflection

This 1990 trial is a reminder that PDRN has been studied in clinical settings for decades, well before its more recent use in skin and regenerative applications. The findings are preliminary, with no comparison group or detailed data, but they are part of a long and varied research record. At Havdis, we see papers like this as one of many steps that have shaped today's wider research interest in PDRN.

Source

De Luca Brunori I, Urbano M, Romani L, Tarani A, Felipetto R, Battini L et al. (1990). Annali di ostetricia, ginecologia, medicina perinatale.

Read the paper on PubMed

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.